Killer Cell Immunoglobulin-like Receptors (KIR) and Human Leucocyte Antigen C (HLA-C) Increase the Risk of Long-Term Chronic Liver Graft Rejection
Open Access
- 12 October 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (20) , 12155
Abstract
Chronic liver rejection (CR) represents a complex clinical situation because many patients do not respond to increased immunosuppression. Killer cell immunoglobulin-like receptors/Class I Human Leukocyte Antigens (KIR/HLA-I) interactions allow for predicting Natural Killer (NK) cell alloreactivity and influence the acute rejection of liver allograft. However, its meaning in CR liver graft remains controversial. KIR and HLA genotypes were studied in 513 liver transplants using sequence-specific oligonucleotides (PCR-SSO) methods. KIRs, human leucocyte antigen C (HLA-C) genotypes, KIR gene mismatches, and the KIR/HLA-ligand were analyzed and compared in overall transplants with CR (n = 35) and no-chronic rejection (NCR = 478). Activating KIR (aKIR) genes in recipients (rKIR2DS2+ and rKIR2DS3+) increased CR compared with NCR groups (p = 0.013 and p = 0.038). The inhibitory KIR (iKIR) genes in recipients rKIR2DL2+ significantly increased the CR rate compared with their absence (9.1% vs. 3.7%, p = 0.020). KIR2DL3 significantly increases CR (13.1% vs. 5.2%; p = 0.008). There was no influence on NCR. CR was observed in HLA-I mismatches (MM). The absence of donor (d) HLA-C2 ligand (dC2−) ligand increases CR concerning their presence (13.1% vs. 5.6%; p = 0.018). A significant increase of CR was observed in rKIR2DL3+/dC1− (p = 0.015), rKIR2DS4/dC1− (p = 0.014) and rKIR2DL3+/rKIR2DS4+/dC1− (p = 0.006). Long-term patient survival was significantly lower in rKIR2DS1+rKIR2DS4+/dC1− at 5–10 years post-transplant. This study shows the influence of rKIR/dHLA-C combinations and aKIR gene-gene mismatches in increasing CR and KIR2DS1+/C1-ligands and the influence of KIR2DS4+/C1-ligands in long-term graft survival.Keywords
Funding Information
- CIBERehd program
- the Projects to Maria Rocio Alvarez-López (04087/GERM/06)
- Séneca Fundación
- Fondo de Investigación Sanitaria del Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, Spain (10/1964)
- Fondo de Investigación Sanitaria del Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, Spain
- Séneca Fundación (04087/GERM/06)
- Ministerio de Educacion (Programa Nacional de Movilidad de Recursos Humanos, Plan Nacional de I-D+i 2008–2011)
This publication has 71 references indexed in Scilit:
- Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefitLiver Transplantation, 2012
- KIR and HLA-C Interactions Promote Differential Dendritic Cell Maturation and Is a Major Determinant of Graft Failure following Kidney TransplantationPLOS ONE, 2011
- Different Patterns of Evolution in the Centromeric and Telomeric Regions of Group A and B Haplotypes of the Human Killer Cell Ig-Like Receptor LocusPLOS ONE, 2010
- Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemiaBlood, 2010
- Linkage disequilibrium organization of the human KIR superlocus: implications for KIR data analysesImmunogenetics, 2010
- Does the KIR2DS5 Gene Protect from Some Human Diseases?PLOS ONE, 2010
- KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-CJournal of Experimental Medicine, 2009
- Donor–Recipient Combinations of Group A and B KIR Haplotypes and HLA class I Ligand Affect the Outcome of HLA-Matched, Sibling Donor Hematopoietic Cell TransplantationHuman Immunology, 2007
- Donation After Cardiac Death as a Strategy to Increase Deceased Donor Liver AvailabilityTransactions of the ... Meeting of the American Surgical Association, 2006
- MHC class I molecules and kirs in human history, health and survivalNature Reviews Immunology, 2005